DrugCards, Tallinn (2026)

21/04/2026

✨ A few days have passed since 2nd Kyiv Drug Safety Day
And we keep thinking about two things.

𝗧𝗵𝗲 𝘁𝗲𝗮𝗺.
Months of work before a single guest arrived. Emails at 11 PM. An agenda rewritten for the fifth time because "this way it'll be better." Smiles at the door even when things weren't going to plan behind the scenes. A belief in this format when it existed only as a Google Sheet.

𝗧𝗵𝗲 𝗿𝗼𝗼𝗺.
Over 80 people who chose to show up. Regulators, academics, healthcare professionals, industry experts - all in one place, talking openly about things that usually stay unsaid. Leadership under pressure. Communication that actually leads to decisions. Pharmacovigilance in a country navigating transformation.
No easy answers. Just honest ones.

We didn't just organize an event. We created a space - and the room felt it.

Thank you to everyone who was there 💙
And thank you to everyone who made it possible.
This is truly just the beginning.

21/04/2026

📦𝗡𝗼𝘁 𝗝𝘂𝘀𝘁 𝗮 𝗕𝗼𝘅: 𝗧𝗵𝗲 𝗙𝗶𝗿𝘀𝘁 𝗟𝗶𝗻𝗲 𝗼𝗳 𝗗𝗲𝗳𝗲𝗻𝗰𝗲 𝗳𝗼𝗿 𝗣𝗮𝘁𝗶𝗲𝗻𝘁𝘀
Most patients don’t read the 📄leaflet - yet medicines are still used safely.
Why? Because packaging does more than we think.
From 🫙child-resistant caps to critical warnings like “𝑭𝒐𝒓 𝒊𝒏𝒕𝒓𝒂𝒗𝒆𝒏𝒐𝒖𝒔 𝒖𝒔𝒆 𝒐𝒏𝒍𝒚”, a single line can prevent serious harm.
🛟This is pharmacovigilance in action - visible, practical, and often overlooked.
👉A new blog article explores how packaging protects patients every day: https://drug-card.io/blog/when-medicine-packaging-becomes-a-lifesaver/

17/04/2026

🎉 2nd Kyiv Drug Safety Day — 𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀

Over 80 participants joined us — and not only from . We brought together regulators, academics, healthcare professionals, and industry experts, showing that leadership and communication go far beyond a single function.

This year, we focused on complex topics — openly and without simplification.

🔹 Borys Lomako set the tone from the very beginning — high energy, strong engagement, and a very practical perspective on leadership as the ability to drive change through people.
🔹 Dmytro Horilyk spoke about leadership through character — not processes, but decisions made under pressure. Real cases and uncomfortable questions: why do we stay silent when it matters most?
🔹 Mykola Romanok delivered a sharp and honest talk on communication. Why management “doesn’t hear,” what actually goes wrong, and how to communicate in a way that leads to decisions.

🔹 Panel discussion: “Who really makes decisions in pharmacovigilance?”
Moderated by Dmytro Horilyk, with:
— Viacheslav Turok (Darnytsia)
— Anton Voitenko (Astellas)
— Myroslava Hubar (Yuria-Pharm)
— Valentyna Yeremenko (Sokola PV Services)
A dynamic, open and at times provocative discussion — exactly the kind that brings honest answers, not just “correct” ones.

🔹 Panel discussion: “Pharmacovigilance in Ukraine under regulatory transformation”
Moderated by Artem Horilyk, with:
— Donets Yevhen (Helsi)
— Tetiana Pohorielova (Novo Nordisk)
— Yevheniia Ishkova (DEC)
A deep and highly relevant discussion combining perspectives from business, regulators, and digital health.

This was more than a pharmacovigilance event.
It was about people, decisions, and responsibility.
Thank you to everyone who joined us 💙
And this is just the beginning.

14/04/2026

𝗪𝗵𝗮𝘁 𝗠𝗮𝗸𝗲𝘀 𝗣𝗩 𝗦𝘆𝘀𝘁𝗲𝗺 𝗜𝗺𝗽𝗹𝗲𝗺𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻 𝗦𝗼 𝗗𝗶𝗳𝗳𝗶𝗰𝘂𝗹𝘁?
Implementing new systems in pharmacovigilance is never “plug and play.” That’s exactly why many teams delay change, even when they know improvements are needed.
🔥We’ve published a new blog post on why PV system implementation feels so difficult, and how it can actually be made simpler and more practical in real workflows.

💡The key idea is simple: implementation doesn’t have to mean replacing everything. It can be gradual, focused, and aligned with real workflows.
👉Read the full article here: https://drug-card.io/blog/implementing-new-systems-in-pharmacovigilance-without-the-pain/

07/04/2026

𝗛𝗼𝘄 𝘀𝗮𝗳𝗲 𝗮𝗿𝗲 𝘁𝗵𝗲 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀 𝗽𝗿𝗲𝘀𝗰𝗿𝗶𝗯𝗲𝗱 𝘁𝗼 𝘄𝗼𝗺𝗲𝗻 𝗼𝗳 𝗿𝗲𝗽𝗿𝗼𝗱𝘂𝗰𝘁𝗶𝘃𝗲 𝗮𝗴𝗲?
Recent data reveal that exposure to contraindicated 💊medications is more common than many realise - even before 🤰pregnancy is detected. From chronic disease management to routine prescriptions, the "hidden window" of risk poses real challenges for pharmacovigilance.

✅Our latest article dives into real-world prescribing patterns, highlights pharmacists' role in preventing unintended exposure, and explores strategies to bridge the gap between guidelines and practice.
Every prescription counts - especially when lives could be affected before pregnancy is even known.

👉Read more and join the discussion on improving medication safety in women: https://drug-card.io/blog/medication-safety-in-women-and-the-burden-of-contraindicated-medicines/

31/03/2026

𝗣𝗿𝗲𝘃𝗲𝗻𝘁𝗮𝗯𝗹𝗲 𝗔𝗱𝘃𝗲𝗿𝘀𝗲 𝗗𝗿𝘂𝗴 𝗥𝗲𝗮𝗰𝘁𝗶𝗼𝗻𝘀 𝗔𝗿𝗲 𝗦𝘁𝗶𝗹𝗹 𝗛𝗮𝗽𝗽𝗲𝗻𝗶𝗻𝗴 - 𝗕𝘂𝘁 𝗪𝗵𝘆?
Our latest blog on the DrugCard platform dives into a persistent challenge in pharmacovigilance: patients being re-exposed to 💊medications that previously caused adverse reactions.

Even when ADRs are 📑documented, gaps in data sharing, fragmented healthcare systems, and limited patient awareness can still lead to preventable harm.
Sometimes, prevention comes down to one simple question at the point of care:
“𝙃𝙖𝙫𝙚 𝙮𝙤𝙪 𝙚𝙭𝙥𝙚𝙧𝙞𝙚𝙣𝙘𝙚𝙙 𝙖 𝙧𝙚𝙖𝙘𝙩𝙞𝙤𝙣 𝙩𝙤 𝙩𝙝𝙞𝙨 𝙢𝙚𝙙𝙞𝙘𝙖𝙩𝙞𝙤𝙣 𝙗𝙚𝙛𝙤𝙧𝙚?”
👉Read the full blog and join the conversation on reducing preventable ADRs: https://drug-card.io/blog/preventable-adverse-drug-reactions-and-the-risk-of-forgotten-reactions/

24/03/2026

🎯𝗪𝗵𝗮𝘁 𝗜𝘁 𝗥𝗲𝗮𝗹𝗹𝘆 𝗠𝗲𝗮𝗻𝘀 𝘁𝗼 𝗪𝗼𝗿𝗸 𝗶𝗻 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗼𝘃𝗶𝗴𝗶𝗹𝗮𝗻𝗰𝗲: 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀 𝗳𝗿𝗼𝗺 𝗮𝗻 𝗘𝘅𝗽𝗲𝗿𝘁
Pharmacovigilance is not just about data - it’s about the people 👤behind every decision.
Stress. Deadlines. Constant responsibility for patient safety. These are not side notes - they’re reality.
💡In our latest blog, we explore what it really means to work in this space. This interview features insights from Reinhold Schilling on how professionals manage workload, stress, and leadership in high-stakes environments.
Because improving pharmacovigilance isn’t only about systems and automation, it’s also about understanding the people behind them.
🧠If you work in drug safety, this perspective will likely feel very familiar: https://drug-card.io/blog/the-human-side-of-pharmacovigilance-stress-workload-and-leadership-in-high-stakes-environments/

16/03/2026

Thank you, Barcelona 🇪🇸
Our vlog from Spain is now available on YouTube – link in bio.
Check it out!

13/03/2026

🚀 Запрошуємо на онлайн вебінар! 🚀

Тема: Штучний інтелект у фармаконагляді: практичні висновки з семінару ISoP у Базелі

📅 Дата: 25 березня, 12:00

🔍 Теми вебінару:

- Огляд звіту CIOMS Working Group XIV про AI у фармаконагляді

- Принципи впровадження AI в фармаконагляд

- AI-агенти у літературному моніторингу

- Аудити та контроль AI-рішень

Спікер: Артем Горілик, директор з розвитку продуктів, DrugCard

💬 Реєстрація: https://drugcards-26507628.hubspotpagebuilder.eu/webinar-isop?utm_source=facebook&utm_medium=facebook&utm_campaign=facebook&utm_id=facebook

Не пропустіть шанс дізнатися більше про інновації у фармаконагляді з використанням штучного інтелекту!

03/03/2026

𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗦𝗮𝗳𝗲𝘁𝘆 𝗦𝘁𝗮𝗿𝘁𝘀 𝗪𝗶𝘁𝗵 𝗪𝗵𝗮𝘁 𝗗𝗼𝗰𝘁𝗼𝗿𝘀 𝗥𝗲𝗽𝗼𝗿𝘁👨🏻‍⚕️
CBD and cannabis oil 🪴are everywhere - people turn to them for pain relief, better sleep, or to calm anxiety. They are often called “natural” and “well-tolerated.” But in reality, what we assume is safe isn’t always harmless.

Fortunately, doctors share their experiences in the 📚medical literature. Published case reports and studies reveal real-world observations, rare reactions, and unexpected interactions that often don’t show up in clinical trials.

👉Read the DrugCard blog to discover why doctors’ insights in the literature are a vital resource for patient safety and smarter pharmacovigilance: https://drug-card.io/blog/cannabis-safety-in-real-life-lessons-from-literature-monitoring/

24/02/2026

💡𝗪𝗵𝘆 𝗦𝗼𝗺𝗲 𝗣𝗿𝗶𝗻𝗰𝗶𝗽𝗹𝗲𝘀 𝗼𝗳 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗼𝘃𝗶𝗴𝗶𝗹𝗮𝗻𝗰𝗲 𝗪𝗶𝗹𝗹 𝗡𝗲𝘃𝗲𝗿 𝗖𝗵𝗮𝗻𝗴𝗲
AI is revolutionising how we handle case intake. Automation accelerates literature 📚screening. Global databases are more connected than ever.
☝️Yet, despite all this innovation, some things remain constant. Patient safety. Clinical judgment. Documentation. Regulatory compliance. Ethical responsibility. No AI, no automation, no global database can replace the human expertise behind every decision.

We often focus on numbers - case reports, signals, trends - but behind every ICSR is a 👤real person. Every report matters. Every assessment matters. Every decision matters.
💬In our latest blog, we dive into the core principles of pharmacovigilance that will never change - and why they remain the foundation of this fast-evolving field: https://drug-card.io/blog/core-principles-of-pharmacovigilance-that-will-never-change/

18/02/2026

🇪🇸 DrugCard at European Drug Safety & AI 2026
Can’t wait to see you there 🙌🏻

DrugCards

21/04/2026

21/04/2026

17/04/2026

14/04/2026

07/04/2026

31/03/2026

24/03/2026

16/03/2026

13/03/2026

03/03/2026

24/02/2026

18/02/2026

Address

Website

Alerts

Contact The Practice

Shortcuts

Share

Category